Organizations Filed Purposes:
TO JOIN TOGETHER LEADING ACADEMIC RESEARCHERS, PHARMACEUTICAL COMPANIES NONPROFIT ORGANIZATIONS, FOUNDATIONS AND GOVERNMENTS WORLDWIDE TO REDUCE TIME, COST AND RISK OF ALZHEIMERS CLINICAL TRIALS IN ORDER TO SPEED INNOVATIVE MEDICINES TO THOSE WITH OR AT RISK OF ALZHEIMERS
THE ORGANIZATION IS ESTABLISHING A STANDING GLOBAL TRIAL-READY PLATFORM TO DRIVE QUALITY, EFFICIENCY, AND INNOVATION IN ALZHEIMERS CLINICAL TRIALS, SEEKING TO REDUCE CLINICAL TESTING CYCLE TIMES BY TWO YEARS AND TO ACHIEVE GREATER UNIFORMITY IN TRIAL POPULATIONS. IT IS DOING THAT BY BUILDING LARGE, WELL-CHARACTERIZED TRIAL-READY COHORTS, AND A NETWORK OF CERTIFIED HIGH-PERFORMANCE CLINICAL TRIAL SITES.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| John Dwyer | PRESIDENT AND CO-FOUNDER | 40 | $525,983 |
| Michael J Glosserman | BOARD MEMBER | 5 | $0 |
| Neil Buckholtz | BOARD MEMBER | 5 | $0 |
| Pascale Witz | BOARD MEMBER | 5 | $0 |
| Drew Holzapfel | FOUNDING BOARD MEMBER | 5 | $0 |
| Steven Paul | FOUNDING BOARD MEMBER | 5 | $0 |
| George Vradenburg | BOARD CHAIR | 20 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202003219349320975_public.xml